These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16462096)

  • 61. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
    Maccarrone M; Finazzi-Agró A
    Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An Introduction to the Endogenous Cannabinoid System.
    Lu HC; Mackie K
    Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA; Varga K; Járai Z; Kunos G
    Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 68. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.
    Hansen HH; Schmid PC; Bittigau P; Lastres-Becker I; Berrendero F; Manzanares J; Ikonomidou C; Schmid HH; Fernández-Ruiz JJ; Hansen HS
    J Neurochem; 2001 Sep; 78(6):1415-27. PubMed ID: 11579150
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils.
    Oka S; Ikeda S; Kishimoto S; Gokoh M; Yanagimoto S; Waku K; Sugiura T
    J Leukoc Biol; 2004 Nov; 76(5):1002-9. PubMed ID: 15316028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
    Alhouayek M; Muccioli GG
    Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain.
    Sugiura T; Yoshinaga N; Kondo S; Waku K; Ishima Y
    Biochem Biophys Res Commun; 2000 May; 271(3):654-8. PubMed ID: 10814517
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors.
    Bonechi C; Martini S; Brizzi V; Brizzi A; Massarelli P; Bruni G; Rossi C
    Eur J Med Chem; 2006 Oct; 41(10):1117-23. PubMed ID: 16837109
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A second endogenous cannabinoid that modulates long-term potentiation.
    Stella N; Schweitzer P; Piomelli D
    Nature; 1997 Aug; 388(6644):773-8. PubMed ID: 9285589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction.
    Schuel H; Goldstein E; Mechoulam R; Zimmerman AM; Zimmerman S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7678-82. PubMed ID: 8052642
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple functions of endocannabinoid signaling in the brain.
    Katona I; Freund TF
    Annu Rev Neurosci; 2012; 35():529-58. PubMed ID: 22524785
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.